---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-000109"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-01-16T23:59:59+00:00"
generated_at: "2026-05-16T09:51:37.841592+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences receives Nasdaq delisting notice for missing annual meeting deadline

## Summary
- Nasdaq notified Artelo on Jan 14, 2026 of non-compliance with the Annual Meeting Rule (5620(a)).
- Annual meeting adjourned from Dec 31, 2025 to Jan 30, 2026 due to insufficient quorum.
- Non-compliance is an additional basis for delisting; company already under equity deficiency (Rule 5550(b)(1)).
- Company will take measures to regain compliance; stock continues trading pending hearing panel decision.
- No assurance that appeal of equity deficiency delisting determination will succeed.

## SEC filing metadata
- accession: 0001640334-26-000109
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-01-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000109/0001640334-26-000109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000109/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-000109
- JSON: https://secwatch.observer/filing/0001640334-26-000109.json
- Plain text: https://secwatch.observer/filing/0001640334-26-000109.txt

## Source-grounded claims
- claim_id: 6e3b493ce64ac833932d3067c16409928fde927b
  claim: ARTELO BIOSCIENCES, INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
  evidence_excerpt: January 14, 2026, the Company received a letter from the Staff of Nasdaq (the “Nasdaq Notice”) indicating that it is not in compliance with Nasdaq Listing Rule 5620(a) (the “Annual Meeting Rule”), which requires companies listed on Nasdaq to hold an annual meeting of shareholders no later than one year after the end of the Company’s fiscal year-end, and, as a result, does not currently satisfy the Annual Meeting Rule. The Staff indicated in the Nasdaq Notice that the Company’s non-compliance with the Annual Meeting Rule could be an additional basis for a delisting determination. The Company ac
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000109/0001640334-26-000109-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.